Gan & Lee Pharmaceuticals. (603087.SS) SHH

69.79

+0.41(+0.59%)

Updated at October 20 11:30AM

Currency In CNY

Valuation

Market Cap26.06B
Enterprise Value25.16B
P/E Ratio44.61
PEG Ratio4.16
Price/Sales Ratio10.85
Price/Book Ratio3.74
Enterprise/Revenue10.56
Enterprise/EBITDA42.15

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.24
Operating Margin0.24

Management Effectiveness

Return On Assets0.08
Return On Equity0.08

Income Statement

Revenue3.05B
Revenue/Share6.42
Gross Profit2.27B
EBITDA545.57M
Net Income614.66M
Diluted EPS1.04

Balance Sheet

Total Cash2.24B
Total Cash/Share3.78
Total Debt2.8M
Total Debt/Equity0
Current Ratio5.4
Book Value Per Share18.55

Price History

52-Week Change40.3
52-Week High82.25
52-Week Low40.4
Moving Average 50 Days72.24
Moving Average 200 Days55.32

Statistics

Average Volume18.32M
Shares Outstanding593.88M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1
Trailing Annual Dividend Yield1.44
Payout Ratio0.35
Last Split Factor7:5
Last Split DateAugust 20, 2020